The (R)-selective amine transaminase from A. fumigatus was purified and crystallized. Diffraction data to 1.84 Å resolution for S-SAD phasing as well as high-resolution data to 1.27 Å were collected from a single crystal belonging to space group C2221.
Keywords: (R)-selective amine transaminase, S-SAD
Abstract
The (R)-selective amine transaminase from Aspergillus fumigatus was expressed in Escherichia coli and purified to homogeneity. Bright yellow crystals appeared while storing the concentrated solution in the refrigerator and belonged to space group C2221. X-ray diffraction data were collected to 1.27 Å resolution, as well as an anomalous data set to 1.84 Å resolution that was suitable for S-SAD phasing.
1. Introduction
Transaminases belong to the pyridoxal-5′-phosphate (PLP)-dependent enzymes and catalyze the reversible transfer of an amino group to an α-keto acid, ketone or aldehyde (Hayashi, 1995 ▶). The PLP and the catalytic lysine side chain are the key elements in this reaction (Eliot & Kirsch, 2004 ▶).
Transaminases are of biotechnological significance because of their ability to produce enantiopure amines from prochiral precursors. These amines are applied as ingredients or synthons in medicine, agrochemistry, pharmacy and chemistry (Merck, 2001 ▶; Deng et al., 1995 ▶; Martens et al., 1986 ▶; Höhne & Bornscheuer, 2009 ▶).
Based on their substrate range, transaminases can be divided into α-transaminases, ω-transaminases and amine transaminases. Whereas the substrates of α-transaminases require a carboxylate in the α position, the substrates of ω-transaminases have up to five extra C atoms between the terminal amino function and the carboxylate. The substrates of amine transaminases can lack the carboxyl group completely (Höhne & Bornscheuer, 2012 ▶; Mani Tripathi & Ramachandran, 2006 ▶). Amine transaminases often show excellent enantioselectivity and can be grouped into two classes. (R)-Amines are generated by (R)-selective amine transaminases when the quinoid intermediate of the reaction is protonated from the catalytic lysine at the si-site (Hanson, 1966 ▶). Alternatively, the (S)-amine is produced by an (S)-amine transaminase when the protonation occurs at the re-site.
Aspergillus fumigatus is a mildew which can cause respiratory allergy. It is a thermophilic saprophytic fungus with a worldwide distribution (Latgé, 1999 ▶). The sequence of an (R)-selective amine transaminase from A. fumigatus was identified by an in silico search (Höhne et al., 2010 ▶) and is available online at NCBI (NCBI Reference Sequence XP_748821.1).
Several structures of α-transaminases have been described and these enzymes have been studied in detail (Schwarzenbacher et al., 2004 ▶; Han et al., 2006 ▶). Recently, a few crystal structures of nonhomologous (S)-selective amine transaminases have been published (Steffen-Munsberg et al., 2013 ▶; Humble et al., 2012 ▶). In contrast, only a homology model of an (R)-selective amine transaminase from an Arthrobacter species based on a d-amino-acid aminotransferase (PDB entry 3daa) has been published (Savile et al., 2010 ▶). Here, we describe expression, purification, crystallization and initial crystallographic results to elucidate the structure of the (R)-selective amine transaminase (AspFum) from A. fumigatus.
2. Materials and methods
2.1. Protein expression and purification
The gene for the amine transaminase was expressed in Escherichia coli BL21 (DE3) cells containing the expression vector pET-22b, which encodes the sequence of the amine transaminase including an additional C-terminal His6 tag (SGSHHHHHH; Höhne et al., 2010 ▶). The recombinant protein consists of 332 amino-acid residues with a molecular weight of 37.16 kDa. The cells were grown at 310 K in 400 ml LB medium containing 0.1 mg ml−1 ampicillin until an OD600 of 0.4 was reached. The temperature was then reduced to the expression temperature of 293 K and the cells were further incubated until they reached an OD600 of 0.7. Expression of the protein was induced by the addition of 1 mM IPTG. The cells were harvested 20 h after induction (Höhne et al., 2010 ▶).
The cell pellet was resuspended in 50 mM sodium phosphate buffer pH 7.5, 300 mM sodium chloride (buffer A) containing an additional 0.1 mM PLP and 30 mM imidazole. Cell disruption was performed by two passages through a French press at 10.3 MPa. The resulting suspension was centrifuged for 45 min at 10 000g. The filtrated supernatant was applied onto a nickel–NTA column (GE Healthcare). After washing with three column volumes of buffer A containing 60 mM imidazole at a flow rate of 5 ml min−1, the protein was eluted with buffer A containing 300 mM imidazole. The amine transaminase-containing fractions were identified using an acetophenone assay (Schätzle et al., 2009 ▶), collected and pooled. The pooled protein was then desalted by gel chromatography against 20 mM tricine buffer pH 7.5, 10 µM PLP at a flow rate of 2 ml min−1 (Höhne et al., 2010 ▶). The desired concentration of AspFum was achieved by ultrafiltration with Vivaspin 6 columns (molecular-weight cutoff 10 kDa; Sartorius Stedim).
2.2. Crystallization
Initial crystallization hits were obtained with a variety of PEG-based conditions (JBScreen Classic 1–10, Jena Bioscience) within 4 d. However, all diffraction images of these crystals were not indexable. Suitable crystals of AspFum appeared after six months in an Eppendorf reaction tube containing concentrated protein (10.7 mg ml−1) and 20 mM tricine pH 7.5 with 10 µM PLP at 277 K. The crystals could easily be seen by eye (>1 mm) and had a very bright yellow colour, suggesting bound PLP (Fig. 1 ▶). Only the small crystals (<0.4 mm) present at the bottom of the tube diffracted to high resolution. The mechanical stress on the large crystals attached to the wall of the reaction tube while fishing and upon cooling led to loss of diffraction quality.
2.3. Data collection and X-ray crystallographic analysis
For cryoprotection, a solution consisting of 35%(v/v) glycerol, 20 mM tricine pH 7.5, 10 µM PLP was used. X-ray diffraction data were collected at 100 K on beamline 14.1 at the BESSY II synchrotron source, Berlin, Germany (Mueller et al., 2012 ▶). Two data sets were collected from one crystal. The first was collected at a wavelength of 0.9184 Å using the highest intensity and the second was collected at 1.77 Å to obtain a large anomalous signal from the S atoms present in the protein. The resolution range of the anomalous data set was limited by the detector geometry. All diffraction images were processed with XDS (Kabsch, 2010 ▶) using the graphical user interface XDSapp (Krug et al., 2012 ▶). The rotation function was calculated using MOLREP (Vagin & Teplyakov, 2010 ▶; Winn et al., 2011 ▶) with a resolution range of 30–3 Å and a radius of integration of 30 Å. Data-collection and processing statistics are given in Table 1 ▶.
Table 1. Data-collection and processing statistics.
Data set | Native | Anomalous |
---|---|---|
Beamline | 14.1, BESSY II | 14.1, BESSY II |
Detector | Pilatus 6M | Pilatus 6M |
Wavelength (Å) | 0.91841 | 1.77122 |
Temperature (K) | 100 | 100 |
Orthorhombic space group | C2221 | C2221 |
Unit-cell parameters (Å) | a = 102.2, b = 120.9, c = 135.4 | a = 102.2, b = 120.9, c = 135.4 |
Resolution range (Å) | 50.0–1.27 (1.35–1.27) | 50.0–1.84 (1.95–1.84) |
No. of unique reflections | 426722 (68273) | 135117 (17260) |
Multiplicity | 3.38 (3.3) | 5.6 (2.6) |
R merge (%) | 6.3 (60.3) | 3.9 (9.5) |
Mean I/σ(I) | 13.2 (2.0) | 30.29 (8.34) |
CC1/2 † (%) | 99.9 (73.0) | 99.9 (98.8) |
Completeness (%) | 99.1 (97.9) | 95.9 (75.8) |
Overall B factor from Wilson plot (Å2) | 17.4 | 18.8 |
Total rotation, increment (°) | 180, 0.1 | 360, 0.1 |
CC1/2 is the percentage correlation between intensities from random half data sets (Karplus & Diederichs, 2012 ▶).
3. Results and discussion
The (R)-selective amine transaminase from A. fumigatus was successful expressed, purified and crystallized and X-ray diffraction data collection was performed. The calculation of the Matthews coefficient V M (Matthews, 1968 ▶) as 2.9 Å3 Da−1 with a corresponding solvent content of 58% for two monomers offers the most probable solution. The self-rotation function (Fig. 2 ▶) shows an independent noncrystallographic twofold axis. Based on the self-rotation function and the Matthews coefficient, we deduced the presence of a dimer in the asymmetric unit. The structure could be solved directly at the beamline using the SAS protocol of the automated crystal structure-determination platform Auto-Rickshaw (Panjikar et al., 2005 ▶), which incorporates SHELXC (Sheldrick, 2001 ▶), SHELXD (Schneider & Sheldrick, 2002 ▶), ABS (Hao, 2004 ▶), SHELXE (Sheldrick, 2002 ▶) and DM (Cowtan, 1994 ▶). Automatic tracing using ARP/wARP (Perrakis et al., 1999 ▶) yielded 97% of the polypeptide model and indeed shows a dimer in the asymmetric unit. Currently, manual completion of the model and refinement against the high-resolution data is in progress.
Similarly to this amine transaminase, we have crystallized another (R)-selective amine transaminase from Neosartorya fischeri (96% sequence identity) from a concentrated protein solution without adding a specific precipitant.
Acknowledgments
MT thanks the Landesgraduiertenkolleg Mecklenburg-Vorpommern for financial support. We thank the European Union (KBBE-2011-5, grant No. 289350) for financial support within the European Union Seventh Framework Programme. Diffraction data were collected on BL14.1 operated by the Helmholtz-Zentrum Berlin (HZB) at the BESSY II electron-storage ring (Berlin-Adlershof, Germany).
References
- Cowtan, K. (1994). Jnt CCP4/ESF–EACBM Newsl. Protein Crystallogr. 31, 34–38.
- Deng, L., Mikusová, K., Robuck, K. G., Scherman, M., Brennan, P. J. & McNeil, M. R. (1995). Antimicrob. Agents Chemother. 39, 694–701. [DOI] [PMC free article] [PubMed]
- Eliot, A. C. & Kirsch, J. F. (2004). Annu. Rev. Biochem. 73, 383–415. [DOI] [PubMed]
- Han, Q., Robinson, H., Gao, Y. G., Vogelaar, N., Wilson, S. R., Rizzi, M. & Li, J. (2006). J. Biol. Chem. 281, 37175–37182. [DOI] [PubMed]
- Hanson, K. R. (1966). J. Am. Chem. Soc. 88, 2731–2742.
- Hao, Q. (2004). J. Appl. Cryst. 37, 498–499.
- Hayashi, H. (1995). J. Biochem. 118, 463–473. [DOI] [PubMed]
- Höhne, M. & Bornscheuer, U. T. (2009). ChemCatChem, 1, 42–51.
- Höhne, M. & Bornscheuer, U. T. (2012). Enzymes in Organic Synthesis, edited by W. Drauz, H. Gröger & O. May, pp. 779–820. Weinheim: Wiley-VCH.
- Höhne, M., Schätzle, S., Jochens, H., Robins, K. & Bornscheuer, U. T. (2010). Nature Chem. Biol. 6, 807–813. [DOI] [PubMed]
- Humble, M. S., Cassimjee, K. E., Håkansson, M., Kimbung, Y. R., Walse, B., Abedi, V., Federsel, H. J., Berglund, P. & Logan, D. T. (2012). FEBS J. 279, 779–792. [DOI] [PubMed]
- Kabsch, W. (2010). Acta Cryst. D66, 125–132. [DOI] [PMC free article] [PubMed]
- Karplus, P. A. & Diederichs, K. (2012). Science, 336, 1030–1033. [DOI] [PMC free article] [PubMed]
- Krug, M., Weiss, M. S., Heinemann, U. & Mueller, U. (2012). J. Appl. Cryst. 45, 568–572.
- Latgé, J.-P. (1999). Clin. Microbiol. Rev. 12, 310–350. [DOI] [PMC free article] [PubMed]
- Mani Tripathi, S. & Ramachandran, R. (2006). J. Mol. Biol. 362, 877–886. [DOI] [PubMed]
- Martens, J., Günther, K. & Schickedanz, M. (1986). Arch. Pharm. 319, 461–465.
- Matthews, B. W. (1968). J. Mol. Biol. 33, 491–497. [DOI] [PubMed]
- Merck (2001). The Merck Index: An Encyclopaedia of Chemicals, Drugs and Biologicals. Whitehouse Station: Merck Manuals.
- Mueller, U., Darowski, N., Fuchs, M. R., Förster, R., Hellmig, M., Paithankar, K. S., Pühringer, S., Steffien, M., Zocher, G. & Weiss, M. S. (2012). J. Synchrotron Rad. 19, 442–449. [DOI] [PMC free article] [PubMed]
- Panjikar, S., Parthasarathy, V., Lamzin, V. S., Weiss, M. S. & Tucker, P. A. (2005). Acta Cryst. D61, 449–457. [DOI] [PubMed]
- Perrakis, A., Morris, R. & Lamzin, V. S. (1999). Nature Struct. Biol. 6, 458–463. [DOI] [PubMed]
- Savile, C. K., Janey, J. M., Mundorff, E. C., Moore, J. C., Tam, S., Jarvis, W. R., Colbeck, J. C., Krebber, A., Fleitz, F. J., Brands, J., Devine, P. N., Huisman, G. W. & Hughes, G. J. (2010). Science, 329, 305–309. [DOI] [PubMed]
- Schätzle, S., Höhne, M., Redestad, E., Robins, K. & Bornscheuer, U. T. (2009). Anal. Chem. 81, 8244–8248. [DOI] [PubMed]
- Schneider, T. R. & Sheldrick, G. M. (2002). Acta Cryst. D58, 1772–1779. [DOI] [PubMed]
- Schwarzenbacher, R. et al. (2004). Proteins, 55, 759–763. [DOI] [PubMed]
- Sheldrick, G. M. (2002). Z. Kristallogr. 217, 644–650.
- Sheldrick, G. M., Hauptman, H. A., Weeks, C. M., Miller, R. & Usón, I. (2001). International Tables for Crystallography, Vol. F, edited by M. G. Rossmann & E. Arnold, pp. 333–351. Dordrecht: Kluwer Academic Publishers.
- Steffen-Munsberg, F., Vickers, C., Thontowi, A., Schätzle, S., Tumlirsch, T., Humble, M. S., Land, H., Berglund, P., Bornscheuer, U. T. & Höhne, M. (2013). ChemCatChem, 5, 150–153.
- Vagin, A. & Teplyakov, A. (2010). Acta Cryst. D66, 22–25. [DOI] [PubMed]
- Winn, M. D. et al. (2011). Acta Cryst. D67, 235–242.